Prague, Czechia

Slavjanka Cernochova

This inventor holds 1 USPTO granted patent. Top assignee: Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu. Active years: 1987.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Slavjanka Cernochova

Introduction

Slavjanka Cernochova is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with potential therapeutic effects. His work has garnered attention for its implications in treating serious health conditions.

Latest Patents

Cernochova holds a patent for "Basic ethers of 7-oxo-7H-benzo(c) fluorene and a process for their preparation." This invention demonstrates pronounced antineoplastic and immunosuppressive effects in mammals suffering from leukemia. The technique involves the aminoalkylation of 5-hydroxy-7-oxo-7H-benzo(c) fluorene and its corresponding nuclear substituted derivatives on the hydroxylic oxygen atom. This innovative approach has the potential to impact cancer treatment significantly.

Career Highlights

Cernochova is associated with Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, a company dedicated to healthcare products. His work at Spofa has allowed him to focus on developing pharmaceutical solutions that address critical health issues. His dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Cernochova has collaborated with notable colleagues, including Ruzena Reichlova and Jiri Krepelka. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Slavjanka Cernochova's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that could benefit many patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…